circumspect dunghill

Thursday, January 31, 2013

Chrysler profit jumps on higher sales

DETROIT (AP) ? Just three years out of bankruptcy, Chrysler posted a $1.7 billion profit in 2012 and said it expects to earn more than $2 billion this year.

Improving U.S. auto sales ? and better products at Chrysler ? were the big reasons for the vast improvement over 2011's profit of $183 million. Chrysler sold 2.2 million cars and trucks worldwide last year, up 18 percent.

In the U.S., its largest market, Chrysler's sales rose 21 percent. Chrysler saw strong sales of the Chrysler 200 and 300 sedans, the Jeep Grand Cherokee and the Ram pickup. The Fiat 500 also sold well last year.

The results mark another step in Chrysler's remarkable turnaround. The company filed for bankruptcy during the recession in 2009 and needed a $12.5 billion loan from taxpayers to survive. Chrysler has repaid $11.2 billion, but the U.S. Treasury Department says it won't recover the remaining $1.3 billion. The profit In 2011 was Chrysler's first annual profit since 1997.

Revenue increased 20 percent to $65.8 billion.

The No. 3 U.S. automaker expects net income to rise to around $2.2 billion this year on revenue of between $72 billion and $75 billion. It says worldwide vehicle shipments should reach 2.6 million to 2.7 million, up from 2.4 million last year.

Chrysler's report comes a day after Ford Motor Co. ? No. 2 in the U.S. ? said it expects to see strong results again this year in North America, but warned of widening losses in Europe. General Motors Co. reports 2012 results on Feb. 14.

Chrysler is now majority owned by Italian automaker Fiat SpA. Sergio Marchionne, CEO of both companies, told the company's 63,643 workers in an email that they would get performance bonus payments, although the amounts were not specified.

"The credit for our turnaround is yours," he told the workers, including 43,000 in the U.S. "There can be no more doubt that our comeback is real. Your phenomenal efforts have put us on a road with an endless horizon in front of us."

In slides posted on its website, Chrysler said it plans to roll out several new and updated vehicles this year and beyond:

? A new small crossover SUV this year to replace the aging Jeep Liberty. Updates to the Grand Cherokee large SUV and the Compass small SUV.

? A new Ram commercial van will debut this year, as well as updated heavy-duty Ram pickup.

? An unspecified new Alfa Romeo vehicle for North America this year.

? A new version of the Chrysler 200 midsize sedan, to debut in 2014.

? The previously announced long version of the Fiat 500 mini-car. No more new products until 2015, when the brand gets up to six new models.

Marchionne also said a new minivan is coming in 2015, but it and other new products have been delayed by a lack of money. "We could have moved on the minivan faster if we had unrestricted access to cash," he said. Chrysler says it spent $4 billion on capital expenditures last year, and it plans to hold that about steady in 2013.

He also said he wants Fiat to fully own Chrysler "as soon as I can afford it." Fiat now owns 58.5 percent of Chrysler, with the rest owned by a health care trust for retired union workers. The trust has asked Chrysler to start the process of a public stock offering so it can sell its shares. Chrysler says the process will take eight to nine months.

"I don't see the future of Fiat and Chrysler as being separate, "Marchionne said. "I see them as one entity at some point in time."

Associated Press

Source: http://hosted2.ap.org/APDEFAULT/f70471f764144b2fab526d39972d37b3/Article_2013-01-30-US-Earns-Chrysler/id-90cc4c8986934ec8927606fa983c1f27

terrell owens terrell owens neil armstrong little league world series us open tennis us open tennis Empire State Building shooting

World Chefs: Thomson dishes up Washington state from Seattle to Spokane

NEW YORK (Reuters) - When food writer Jess Thomson moved to Seattle, Washington, she expected to find the adventuresome cooking for which the city is famous. But she admits to being pleasantly surprised by the rich diversity of the rest of the state.

The 150 recipes in her book "Dishing Up Washington" attempt to capture the authentic regional flavors of the entire state, from Seattle to Spokane, Yakima to Walla Walla.

"It is a total food heaven," said Thomson, cookbook author, recipe developer and food blogger. "I knew it would be delicious but I'm not sure I knew how much would be available here and how constantly I would be bombarded with really great food."

She spoke to Reuters about discovering the distinctive foods of Washington and the state's climate and locavore tradition.

Q: Is this your first cookbook?

A: "This is my fourth cookbook; three in my name, one that I ghostwrote."

Q: Did you write the recipes for this book?

A: "The book is a little bit unique because it is about 60 percent recipes that I've written inspired by the state's ingredients and about 40 percent recipes by chefs, farmers and artisans from all over the state."

Q: What was your purpose with this book?

A: "I wanted to show not just best restaurants but ingredients that drive those restaurants -- what it's like to run a potato farm and the simple potato soup the farmer's mother makes, which is super warming, super delicious but not high-falutin chef-y approach that I think many Seattle chefs might have taken ... I wanted to show the guy who grows saffron on the Olympic peninsula, and the tomato grower in northeastern Washington. She doesn't have a restaurant but she's important to the state because she grows these really fantastic tomatoes."

Q: How would you characterize the cuisine of Washington State?

A: "It's adventuresome coastal cooking that depends heavily on local ingredients."

Q: Which ingredients are typical of the state?

A: "Stone fruits like peaches and cherries are huge here; tree fruits like apples and pears; fish and shellfish, mainly crab, oysters, mussels, and salmon. Then there's really great dairy and cheese, mostly from the northwestern part of the state. The state is also well known for larger crops like grapes, wheat and beef."

Q: How does Seattle's famously rainy climate affect the cuisine?

A: "The state is sort of divided by the Cascade Mountains into two distinct climates: the wet half towards the west and the drier half towards the east ... (But) there's a giant misconception about the rain here. Boston gets more rain than Seattle, but Seattle gets it almost every day of the week in winter. From a food perspective this is a very good climate for growing. Drought is not really an issue here. On the eastern side drought is an issue but many areas there get more than 300 days of sunshine in a year, so the growing season is very long and the conditions are great."

Q: What accounts for the strong locavore tradition?

A: "Because it's available. Farmers' markets near me are open the year round. In February maybe I can't buy cherries but I can buy great kale, radicchio and hazelnuts. I think it's such a vibrant community because the weather allows us to get food year round. The food world doesn't shut down from November to April here."

Q: Who is your book aimed at?

A: "I wanted to make it approachable for people cooking anywhere. The chef recipes are a little more complicated and difficult. The recipes that I've written are much simpler ... This book also an edible tour guide to the state. People tell me they're using it as a travel guide, keeping it in their car as a way of deciding what restaurants to go to in Seattle and the state."

Northwest Crab Chowder

2 tablespoons unsalted butter

1 yellow onion, finely chopped

4 stalks celery, cut into quarter-inch slices

1 tablespoon finely chopped fresh thyme

Salt

Freshly ground black pepper

2 pounds Yukon Gold potatoes (about 7 medium), cut into half-inch chunks

2 cups whole milk

1 cup heavy cream

1 (15-ounce) can fish broth

1 (8-ounce) bottle clam juice

1.5 pounds Dungeness crabmeat, chopped

6 servings

1. Melt the butter in a large soup pot over medium heat. Add the onions, celery, and thyme. Salt and pepper to taste, and cook, stirring, until the vegetables start to soften, about 5 minutes. Add the potatoes, milk, cream, fish broth and clam juice. Bring the soup to a simmer and cook until the potatoes are soft, about 10 minutes.

2. Transfer about 2 cups of the vegetables to a food processor or a blender, blend until smooth, and return to the pot. Stir in the crabmeat, cook for 5 minutes longer, and salt and pepper to taste. Serve piping hot.

(Editing by Patricia Reaney and Doina Chiacu)

(This story corrects spelling of Thomson in slug, headline and throughout)

Source: http://news.yahoo.com/world-chefs-thomson-dishes-washington-state-seattle-spokane-172607626.html

kevin costner whitney houston whitney houston funeral live pat buchanan slither slither naacp glen campbell

Retailer planning jobs for spring season

LOUISVILLE, KY (WAVE) - Winter is not quite over, but a home-improvement retailer is already looking forward to spring.

Lowe's plans to hire 45,000 seasonal workers ahead of the busy season.

Seasonal employees will work an average of 20 to 25 hours per week and the length of employment will vary.

Most of the jobs will begin in the spring and could last until September.

For more information or to apply for the positions, click here.

Source: http://stmatthews-lyndon.wave3.com/news/news/112427-retailer-planning-jobs-spring-season

Samantha Steele Espn goog Sylvia Kristel st louis cardinals Steelers Schedule tory burch Al Smith Dinner

A-Rod denies PED use report; MLB investigates

FILE - In this Wednesday, Oct. 17, 2012 file photo, New York Yankees' Alex Rodriguez takes batting practice before Game 4 of the American League championship series against the Detroit Tigers, in Detroit. Major League Baseball says it is "extremely disappointed" about a new report that says records from an anti-aging clinic in the Miami area link Rodriguez and other players to the purchase of performance-enhancing drugs. (AP Photo/Carlos Osorio, File)

FILE - In this Oct. 18, 2012 file photo, New York Yankees' Alex Rodriguez prepares to hit in the sixth inning during Game 4 of the American League championship series against the Detroit Tigers in Detroit. Major League Baseball says it is "extremely disappointed" about a new report that says records from an anti-aging clinic in the Miami area link Rodriguez and other players to the purchase of performance-enhancing drugs. (AP Photo/Matt Slocum, File)

This undated booking photo provided by the Miami-Dade Police Department, on Tuesday, Jan 29, 2013, shows Anthony Bosch. Major League Baseball says it is "extremely disappointed" about a new report that says records from an anti-aging clinic in the Miami area link New York Yankees star Alex Rodriguez and other players to the purchase of performance-enhancing drugs. The Miami New Times said in a story on Tuesday that it had obtained files through an employee at a recently closed clinic called Biogenesis. The report said that the notes of clinic chief Bosch list the players' names and the substances they received, including human growth hormone and steroids. (AP Photo/Miami-Dade Police Department)

FILE - In this Aug. 12, 2012, file photo, Oakland Athletics starter Bartolo Colon tosses the ball after Chicago White Sox's Gordon Beckham hit a two-run single during the sixth inning of a baseball game in Chicago. Major League Baseball says it is "extremely disappointed" about a new report that says records from an anti-aging clinic in the Miami area link Alex Rodriguez and other players to the purchase of performance-enhancing drugs. The Miami New Times said in a story Tuesday, Jan. 29, 2013, that it had obtained files through an employee at a recently closed clinic called Biogenesis. Other players named by the publication as appearing in the records include Colon, Melky Cabrera, Gio Gonzalez and Nelson Cruz.(AP Photo/Nam Y. Huh, File)

FILE - In this June 12, 2012, file photo, Texas Rangers' Nelson Cruz breaks his bat while hitting a double during the second inning of their baseball game against the Los Angeles Angels in Anaheim, Calif. Major League Baseball says it is "extremely disappointed" about a new report that says records from an anti-aging clinic in the Miami area link Alex Rodriguez and other players to the purchase of performance-enhancing drugs. The Miami New Times said in a story Tuesday, Jan. 29, 2013, that it had obtained files through an employee at a recently closed clinic called Biogenesis. Other players named by the publication as appearing in the records include Cruz, Melky Cabrera, Gio Gonzalez and Bartolo Colon. (AP Photo/Mark J. Terrill, File)

NEW YORK (AP) ? Alex Rodriguez denied a newspaper report that accused him of buying human growth hormone and other performance-enhancing substances from a Miami-area clinic.

The Miami New Times, an alternative weekly, reported Tuesday that it obtained records detailing purchases by Rodriguez, Melky Cabrera, Gio Gonzalez, Bartolo Colon, Nelson Cruz and Yasmani Grandal from a clinic called Biogenesis, run by Anthony Bosch. The paper also posted copies of what it said were Bosch's handwritten records, obtained through a former Biogenesis employee.

Rodriguez admitted four years ago that he used PEDs from 2001-03. Cabrera, Colon and Grandal were suspended for 50 games each last year by MLB following tests for elevated testosterone.

"We are always extremely disappointed to learn of potential links between players and the use of performance-enhancing substances," MLB said in a statement. "Only law enforcement officials have the capacity to reach those outside the game who are involved in the distribution of illegal performance-enhancing drugs. ... We are in the midst of an active investigation and are gathering and reviewing information."

A baseball official, speaking on condition of anonymity because he was not authorized to make public statements, said Monday that MLB did not have any documentation regarding the allegations. If MLB does obtain evidence, the players could be subject to discipline. First offenses result in a 50-game suspension and second infractions in 100-game penalties. A third violation results in a lifetime ban.

Rodriguez is sidelined for at least the first half of the season after hip surgery Jan. 16. A 50-game suspension would cost him $7.65 million of his $28 million salary.

"The news report about a purported relationship between Alex Rodriguez and Anthony Bosch are not true," Rodriguez said in a statement issued by a publicist. "He was not Mr. Bosch's patient, he was never treated by him and he was never advised by him. The purported documents referenced in the story ? at least as they relate to Alex Rodriguez ? are not legitimate."

Jay Reisinger, a lawyer who has presented Rodriguez in recent years, said the three-time AL MVP had retained Roy Black, an attorney from Rodriguez's hometown of Miami. Black's clients have included Rush Limbaugh and William Kennedy Smith.

Rodriguez spent years denying he used PEDs before Sports Illustrated reported in February 2009 that he tested positive for two steroids in MLB's anonymous survey while with the Texas Rangers in 2003. Two days later, he admitted in an ESPN interview that he used PEDs over a three-year period. He has denied using PEDs after 2003.

If the new allegations were true, the Yankees would face high hurdles to get out of the final five years of Rodriguez's contract, which call for him to receive $114 million. Because management and the players' union have a joint drug agreement, an arbitrator could determine that any action taken by the team amounted to multiple punishments for the same offense.

The Yankees said "this matter is now in the hands of the commissioner's office" and said they will not comment further until MLB's investigation ends.

Gonzalez posted on his Twitter feed: "I've never used performance enhancing drugs of any kind and I never will, I've never met or spoken with tony Bosch or used any substance provided by him. anything said to the contrary is a lie."

Colon was not issuing a statement, agent Adam Katz said through spokeswoman Lisa Cohen. Sam and Seth Levinson, the agents for Cabrera and Cruz, did not immediately respond to emails seeking comment.

Cruz and Gonzalez had not previously been linked to performance-enhancing drugs. Cruz's team, the Texas Rangers, said it notified MLB last week after being contacted by the New Times.

The New Times report said it obtained notes by Bosch listing the players' names and the substances they received. Several unidentified employees and clients confirmed to the publication that the clinic distributed the substances, the paper said. The employees said that Bosch bragged of supplying drugs to professional athletes but they never saw the sports stars in the office.

Rodriguez appears 16 times in the documents it received, the paper said, either as "Alex Rodriguez," ''Alex Rod" or the nickname "Cacique," a pre-Columbian Caribbean chief. The paper said the records list that Rodriguez paid for HGH; testosterone cream; IGF-1, a substance banned by baseball that stimulates insulin production; and GHRP, which releases growth hormones.

Rodriguez's cousin, Yuri Sucart, also is listed as having purchased HGH. Sucart was banned from the Yankees clubhouse, charter flights, bus and other team-related activities by MLB in 2009 after Rodriguez said Sucart obtained and injected PEDs for him.

Also listed among the records, according to the New Times, are tennis player Wayne Odesnik, Cuban boxer Yuriorkis Gamboa and Jimmy Goins, the strength and conditioning coach of the University of Miami baseball team.

Mia Ro, a spokeswoman for the federal Drug Enforcement Administration in Miami, said she could not confirm or deny the existence of an investigation in Bosch or the clinic.

Associated Press

Source: http://hosted2.ap.org/APDEFAULT/347875155d53465d95cec892aeb06419/Article_2013-01-29-MLB-Drug%20Investigation/id-850bdca282564cb69512f7ff55c8ff71

kevin costner whitney houston whitney houston funeral live pat buchanan slither slither naacp glen campbell

Wednesday, January 30, 2013

Scientists learn more about how inhibitory brain cells get excited

Jan. 30, 2013 ? Scientists have found an early step in how the brain's inhibitory cells get excited. A natural balance of excitement and inhibition keeps the brain from firing electrical impulses randomly and excessively, resulting in problems such as schizophrenia and seizures. However excitement is required to put on the brakes.

"When the inhibitory neuron is excited, its job is to suppress whatever activity it touches," said Dr. Lin Mei, Director of the Institute of Molecular Medicine and Genetics at the Medical College of Georgia at Georgia Regents University and corresponding author of the study in Nature Neuroscience.

Mei and his colleagues found that the protein erbin, crucial to brain development, is critical to the excitement.

It was known that a protein on the cell surface called TARP gamma-2, also known as stargazing, interacts with a brain cell receptor called AMPA, ensuring the receptor finds the cells surface. It is here that the receptor can be activated by the neurotransmitter glutamate. AMPA receptor activation is essential to activation of the NMDA receptor, which enables cells to communicate, ultimately enabling learning and memory, Mei said. How TARP gamma-2 was controlled, was an unknown.

Inside the nucleus of inhibitory cells in areas of the brain that control learning and memory, the researchers found erbin interacts with TARP gamma-2, enabling it to survive. "If you do not have this mechanism, your stargazing becomes very unstable and your AMPA receptor cannot be on the surface so this neuron is inactive," Mei said. They also found that erbin is only in these inhibitory neurons, called interneurons. They're already working on what they believe to be the counterpart for excitatory cells, which account for about 80 percent of brain cells.

"Interneurons basically control firing," releasing GABA, a major inhibitory neurotransmitter, Mei said. They tone down or synchronize the activity of pyramidal cells, pyramid-shaped neurons that get both excitatory and inhibitory input then make the call on what action to take.

When scientists ablated the erbin gene in mice or kept erbin from interacting with TARP gamma-2, a protein that helps anchor the AMPA receptor on the cell surface, TARP gamma-2 couldn't do its job. The result was less receptors on the cell surface and mice that were hyperactive with impaired learning and memory.

Cell activity hinges on receptor activity and receptors must be anchored on the cell surface to work. Ensuring AMPA receptors are strategically placed is a lifelong task since the busy receptors wear out and each brain cell has tons of them, Mei said.

He and his colleagues reported in the journal, Neuron, in 2007, two genes -- neuregulin-1 and its receptor ErbB4 -- that help maintain a healthy balance of excitement and inhibition by releasing GABA at the sight of inhibitory synapses, the communication paths between neurons. Years before, they showed the genes were also at excitatory synapses, where they also could quash activation. Both genes are involved in human development and implicated in schizophrenia and cancer.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

Story Source:

The above story is reprinted from materials provided by Georgia Health Sciences University. The original article was written by Toni Baker.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.

Journal Reference:

Yanmei Tao, Yong-Jun Chen, Chengyong Shen, Zhengyi Luo, C Ryan Bates, Daehoon Lee, Sylvie Marchetto, Tian-Ming Gao, Jean-Paul Borg, Wen-Cheng Xiong, Lin Mei. Erbin interacts with TARP ?-2 for surface expression of AMPA receptors in cortical interneurons. Nature Neuroscience, 2013; DOI: 10.1038/nn.3320

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/most_popular/~3/5e3pfQjjfxE/130130121641.htm

maine caucus whitney houston has died blue ivy carter whitney houston death the vow the voice season 2 ron paul maine

Artificial pancreas: The way of the future for treating type 1 diabetes

Jan. 28, 2013 ? IRCM researchers, led by endocrinologist Dr. R?mi Rabasa-Lhoret, were the first to conduct a trial comparing a dual-hormone artificial pancreas with conventional diabetes treatment using an insulin pump and showed improved glucose levels and lower risks of hypoglycemia. Their results, published January 28 in the Canadian Medical Association Journal (CMAJ), can have a great impact on the treatment of type 1 diabetes by accelerating the development of the external artificial pancreas.

The artificial pancreas is an automated system that simulates the normal pancreas by continuously adapting insulin delivery based on changes in glucose levels. The dual-hormone artificial pancreas tested at the IRCM controls glucose levels by automatically delivering insulin and glucagon, if necessary, based on continuous glucose monitor (CGM) readings and guided by an advanced algorithm.

"We found that the artificial pancreas improved glucose control by 15 per cent and significantly reduced the risk of hypoglycemia as compared with conventional insulin pump therapy," explains engineer Ahmad Haidar, first author of the study and doctoral student in Dr. Rabasa-Lhoret's research unit at the IRCM and at the Department of Electrical and Computer Engineering at McGill University. "The artificial pancreas also resulted in an 8-fold reduction of the overall risk of hypoglycemia, and a 20-fold reduction of the risk of nocturnal hypoglycemia."

People living with type 1 diabetes must carefully manage their blood glucose levels to ensure they remain within a target range. Blood glucose control is the key to preventing serious long-term complications related to high glucose levels (such as blindness or kidney failure) and reduces the risk of hypoglycemia (dangerously low blood glucose that can lead to confusion, disorientation and, if severe, loss of consciousness).

"Approximately two-thirds of patients don't achieve their target range with current treatments," says Dr. Rabasa-Lhoret, Director of the Obesity, Metabolism and Diabetes research clinic at the IRCM. "The artificial pancreas could help them reach these targets and reduce the risk of hypoglycemia, which is feared by most patients and remains the most common adverse effect of insulin therapy. In fact, nocturnal hypoglycemia is the main barrier to reaching glycemic targets."

"Infusion pumps and glucose sensors are already commercially-available, but patients must frequently check the sensor and adjust the pump's output," says Mr. Haidar. "To liberate them from this sizable challenge, we needed to find a way for the sensor to talk to the pump directly. So we developed an intelligent dosing algorithm, which is the brain of the system. It can constantly recalculate insulin dosing based on changing glucose levels, in a similar way to the GPS system in a car, which recalculates directions according to traffic or an itinerary change."

The researchers' algorithm, which could eventually be integrated as software into a smart phone, receives data from the CGM, calculates the required insulin (and glucagon, if needed) and wirelessly controls the pump to automatically administer the proper doses without intervention by the patient.

"The system we tested more closely mimics a normal pancreas by secreting both insulin and glucagon," adds Dr. Laurent Legault, peadiatric endocrinologist and outgoing Director of the Insulin Pump Centre at the Montreal Children's Hospital, and co-author of the study. "While insulin lowers blood glucose levels, glucagon has the opposite effect and raises glucose levels. Glucagon can protect against hypoglycemia if a patient with diabetes miscalculates the necessary insulin dose."

"Our work is exciting because the artificial pancreas has the potential to substantially improve the management of diabetes and reduce daily frustrations for patients," concludes Dr. Rabasa-Lhoret. "We are pursuing our clinical trials to test the system for longer periods and with different age groups. It will then probably be introduced gradually to clinical practice, using insulin alone, with early generations focusing on overnight glucose controls."

This study was conducted with 15 adult patients with type 1 diabetes, who had been using an insulin pump for at least three months. Patients were admitted twice to the IRCM's clinical research facility and received, in random order, both treatments: the dual-hormone artificial pancreas and the conventional insulin pump therapy. During each 15-hour visit, their blood glucose levels were monitored as they exercised on a stationary bike, received an evening meal and a bedtime snack, and slept at the facility overnight.

Dr. Rabasa-Lhoret's research is funded by Diabetes Qu?bec, the Canadian Diabetes Association, and the IRCM's J.A. De S?ve Chair in clinical research. IRCM collaborators who contributed to study include Maryse Dallaire, Ammar Alkhateeb, Ad?le Coriati, Virginie Messier and Maude Millette.

About diabetes

Type-1 diabetes is a chronic, incurable disease that occurs when the body doesn't produce enough or any insulin, leading to an excess of sugar in the blood. It occurs most often in children, adolescents or young adults. People with type-1 diabetes depend on insulin to live, either through daily injections or with a pump. Diabetes is a major cause of vision loss, kidney and cardiovascular diseases.

According to the Canadian Diabetes Association, an estimated 285 million people worldwide are affected by diabetes, approximately 10 per cent of which have type 1 diabetes. With a further 7 million people developing diabetes each year, this number is expected to hit 438 million by 2030, making it a global epidemic.?

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

Story Source:

The above story is reprinted from materials provided by Institut de recherches cliniques de Montreal.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.

Journal Reference:

Ahmad Haidar, Laurent Legault, Maryse Dallaire, Ammar Alkhateeb, Ad?le Coriati, Virginie Messier, Peiyao Cheng, Maude Millette, Benoit Boulet, Chiu-Ching Huang, R?mi Rabasa-Lhoret. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. Canadian Medical Association Journal, 2013 DOI: 10.1503/cmaj.121265

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/most_popular/~3/IsBFXJa7YCU/130128151928.htm

Daily Caller Staten Island Trick or Treat Amy Weber Happy Halloween! Star Wars Episode 7 miranda lambert

CIS Top 10 Tuesday: UBC Okanagan women's volleyball now 9th ...

CIS Top 10 Tuesday

OTTAWA (CIS)?? There are three changes atop CIS national rankings this week. The UNB Varsity Reds return to #1 in men?s hockey, while the Toronto Varsity Blues and Guelph Gryphons take the lead in women?s and men?s track and field, respectively.

In other CIS sports, Windsor (women?s basketball), Carleton (men?s basketball), McGill (women?s hockey), UBC (women?s swimming & women?s volleyball), Toronto (men?s swimming) and Alberta (men?s volleyball, women?s & men?s wrestling) all maintain their #1 status.

WOMEN?S BASKETBALL
(regular season record) / votes (first-place votes) / (previous rankings)
1. Windsor (15-0) / 515 points (42) / (1)
2. Saint Mary?s (13-0) / 465 (1) / (2)
3. Regina (14-2) / 434 / (3)
4. Fraser Valley (13-3) / 380 / (4)
5. Carleton (13-3) / 352 / (5)
6. UBC (12-4) / 295 / (6)
7. Brock (14-1) / 221 / (7)
8. Calgary (14-2) / 206 / (10)
9. Victoria (11-5) / 172 / (8)
10. Concordia (7-3) / 111 / (9)

Other votes: Acadia (96), Ottawa (71)

MEN?S BASKETBALL
(regular season record) / votes (first-place votes) / (previous rankings)
1. Carleton (15-1) / 491 points (40) / (1)
2. UBC (14-2) / 450 (1) / (2)
3. Cape Breton (14-0) / 410 / (3)
4. Windsor (12-3) / 367 / (5)
5. Acadia (9-3) / 301 / (6)
6. Alberta (13-3) / 299 / (4)
7. Ryerson (12-2) / 265 / (7)
8. Ottawa (12-4) / 130 / (8)
9. Fraser Valley (9-7) / 111 / (NR)
10. McGill (6-3) / 97 / (9)

Other votes:?Saskatchewan (91),?Lakehead (89)

WOMEN?S HOCKEY
(regular season record) / (previous rankings)
1. McGill (15-0-0) / (1)
2. Calgary (20-3-1) / (2)
3. Montreal (13-3-0) / (4)
4. Laurier (19-1-3) / (3)
5. St. FX (19-1-0) / (5)
6. Guelph (18-3-2) / (8)
7. Queen?s (17-3-2) / (6)
8. Alberta (15-8-1) / (7)
9. Western (16-5-1) / (9)
10. Regina (15-7-2) / (10)

MEN?S HOCKEY
(regular season record) / votes (first-place votes) / (previous rankings)
1. UNB (20-5-0) / 151 points (8) / (2)
2. Alberta (19-4-1) / 147 (6) / (1)
3. Western (20-4-0) / 131 (2) / (3)
4. UQTR (18-5-1) / 93 / (7)
5. Saint Mary?s (16-7-2) / 81 / (4)
6. Acadia (16-7-2) / 72 / (6)
7. Saskatchewan (16-7-1) / 69 / (5)
8. Manitoba (15-5-4) / 57 / (9)
9. Carleton (17-6-2) / 30 / (8)
10. Calgary (15-9-0) / 26 / (10)

Other votes: UPEI (12), Guelph (8), Windsor (3)

WOMEN?S SWIMMING
(points) / (previous rankings)
1. UBC 668 points / (1)
2. Calgary 487 / (3)
3. Toronto 281 / (2)
4. Montreal 254 / (4)
5. UQTR 166 / (7)
6. Dalhousie 162 / (5)
7. Alberta 161 / (6)
8. Western 155 / (NR)
9. McMaster 106 / (8)
10. Laval 101 / (NR)

MEN?S SWIMMING
1. Toronto 463 points / (1)
2. Calgary 422 / (5)
3. UBC 396 / (3)
4. Alberta 258 / (2)
5. Laval 214 / (4)
6. Victoria 210 / (7)
7. Western 184 / (NR)
8. Dalhousie 126 / (6)
9. McMaster 113 / (9)
10. Lethbridge 112 / (10)

WOMEN?S TRACK & FIELD
(points) / (previous rankings)
1. Toronto 92 points / (4)
2. Guelph 88 / (2)
3. Calgary 83 / (1)
4. Windsor 76 / (3)
5. Western 47 / (5)
6. Saskatchewan 42 / (6)
7. Trinity Western 41 / (8)
8. Ottawa 31 / (NR)
9. Montreal 26.5 / (NR)
10. Regina 25 / (7)

MEN?S TRACK & FIELD
1. Guelph 101.5 points / (2)
T2. Laval 67 / (7)
T2. Ottawa 67 / (6)
4. Sherbrooke 62.33 / (3)
5. York 59.33 / (4)
6. Western 54.33 / (5)
7. Windsor 52 / (1)
8. Regina 32 / (10)
9. Dalhousie 29.5 / (NR)
10. Calgary 25.83 / (NR)

WOMEN?S VOLLEYBALL
(regular season record) / votes / (previous rankings)
1. UBC (17-1) / 60 points / (1)
2. Trinity Western (16-2) / 56 / (2)
3. Dalhousie (13-2) / 50.5 / (4)
4. Ottawa (15-1) / 46.5 / (7)
5. York (13-1) / 44 / (5)
6. Alberta (13-5) / 43 / (3)
7. Montreal (12-6) / 34.5 / (T10)
8. Laval (14-4) / 33.5 / (6)
9. UBC Okanagan (11-7) / 27 / (8)
10. Sherbrooke (14-4) / 24 / (9)

Other votes:?Mount Royal (21), Calgary (16), Queen?s (8.5), Manitoba (7), Saint Mary?s (5.5).

MEN?S VOLLEYBALL
(regular season record) / votes (first-place votes) / (previous rankings)
1. Alberta (18-0) / 270 points (27) / (1)
2. McMaster (15-0) / 237 (1) / (2)
3. Laval (16-0) / 202 / (3)
4. Manitoba (12-6) / 196 / (4)
5. Trinity Western (13-5) / 182 / (5)
6. Saskatchewan (12-6) / 132 / (8)
7. UBC (12-6) / 117 / (7)
8. Brandon (10-8) / 88 / (6)
9. Winnipeg (8-10) / 48 / (9)
10. Waterloo (13-2) / 40 / (10)

WOMEN?S WRESTLING
(previous rankings)
1. Alberta (1)
2. Brock (2)
3. Regina (3)
4. Western (4)
5. Calgary (5)
6. Saskatchewan (6)
7. Lakehead (7)
8. Concordia (8)
9. McMaster (9)
10. UNB (10)

MEN?S WRESTLING
1. Alberta (1)
2. Concordia (2)
3. Western (3)
4. Brock (4)
5. McMaster (5)
6. Guelph (6)
T7. Regina (T7)
T7. UNB (T7)
9. Saskatchewan (9)
10. Calgary (10)

About Canadian Interuniversity Sport
Canadian Interuniversity Sport is the national governing body of university sport in Canada. Every year, 11,000 student-athletes and 700 coaches from 54 universities and four regional associations vie for 21 national championships in 12 different sports. CIS also provides high performance international opportunities for Canadian student-athletes at Winter and Summer Universiades, as well as numerous world university championships. For further information, visit www.cis-sic.ca or follow us on:

Twitter
Facebook
YouTube

Source: https://news.ok.ubc.ca/athrec/2013/01/29/cis-top-10-tuesday-ubc-okanagan-womens-volleyball-now-9th/

Claire Danes quentin tarantino jessica chastain jessica chastain hugh jackman Amy Poehler Australian Open